Based in Boston and St. Gallen, juli is an AI-powered digital health platform empowering patients and their care teams to manage complex chronic conditions. Over 15,000 patients have used the juli app since its launch in 2021. The startup has now secured $3.8 million in a seed-funding round led by Speedinvest and Norrsken VC to grow its US base and accelerate clinical developments.